{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T04:25:48Z","timestamp":1729139148924,"version":"3.27.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,16]]},"DOI":"10.7759\/cureus.71634","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:10:49Z","timestamp":1729095049000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Extracranial Giant Cell Arteritis in a Patient With Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Oscar Vicente","family":"Vergara-Serpa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana Margarita","family":"Vega Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuleidis del Carmen","family":"Mozo Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Juliana","family":"Mantilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Camilo","family":"Santacruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou M","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020, 172:ITC81-96. 10.7326\/AITC202006020","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2018.09.004","article-title":"Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus","volume":"32","author":"Gergianaki I","year":"2018","unstructured":"Gergianaki I, Bortoluzzi A, Bertsias G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2018, 32:188-205. 10.1016\/j.berh.2018.09.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel CH","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024, 331:1480-91. 10.1001\/jama.2024.2315","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000216817.35937.70","article-title":"Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients","volume":"85","author":"Ramos-Casals M","year":"2006","unstructured":"Ramos-Casals M, Nardi N, Lagrutta M, et al.. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore). 2006, 85:95-104. 10.1097\/01.md.0000216817.35937.70","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320950017","article-title":"Lupus aortitis: A fatal, inflammatory cardiovascular complication in systemic lupus erythematosus","volume":"29","author":"Akiyama M","year":"2020","unstructured":"Akiyama M, Kaneko Y, Takeuchi T. Lupus aortitis: A fatal, inflammatory cardiovascular complication in systemic lupus erythematosus. Lupus. 2020, 29:1652-4. 10.1177\/0961203320950017","journal-title":"Lupus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2023.2190288","article-title":"Giant cell arteritis","volume":"135","author":"Pepper K","year":"2023","unstructured":"Pepper K. Giant cell arteritis. Postgrad Med. 2023, 135:22-32. 10.1080\/00325481.2023.2190288","journal-title":"Postgrad Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3050","article-title":"Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis","volume":"180","author":"van der Geest KS","year":"2020","unstructured":"van der Geest KS, Sandovici M, Brouwer E, Mackie SL. Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis. JAMA Intern Med. 2020, 180:1295-304. 10.1001\/jamainternmed.2020.3050","journal-title":"JAMA Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50299","article-title":"Updates on the prognosis of giant cell arteritis: a systematic review","volume":"15","author":"Abukanna AM","year":"2023","unstructured":"Abukanna AM, Alanazi YF, Alanazi FW, et al.. Updates on the prognosis of giant cell arteritis: a systematic review. Cureus. 2023, 15:e50299. 10.7759\/cureus.50299","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte C","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, et al.. 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022, 81:1647-53. 10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.42324","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","volume":"74","author":"Grayson PC","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, et al.. 2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis. Arthritis Rheumatol. 2022, 74:1872-80. 10.1002\/art.42324","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24055","article-title":"Patterns of arterial disease in Takayasu arteritis and giant cell arteritis","volume":"72","author":"Gribbons KB","year":"2020","unstructured":"Gribbons KB, Ponte C, Carette S, et al.. Patterns of arterial disease in Takayasu arteritis and giant cell arteritis. Arthritis Care Res (Hoboken). 2020, 72:1615-24. 10.1002\/acr.24055","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00398-2","article-title":"Systemic lupus erythematosus","volume":"403","author":"Hoi A","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, et.al.. Systemic lupus erythematosus. Lancet Lond Engl. 2024, 403:2326-38. 10.1016\/S0140-6736(24)00398-2","journal-title":"Lancet Lond Engl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/1573397113666170704102444","article-title":"Cardiovascular and pulmonary manifestations of systemic lupus erythematosus","volume":"13","author":"Tselios K","year":"2017","unstructured":"Tselios K, Urowitz MB. Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev. 2017, 13:206-18. 10.2174\/1573397113666170704102444","journal-title":"Curr Rheumatol Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2948-4","article-title":"Chest pain in lupus patients: the emergency department experience","volume":"34","author":"Modi M","year":"2015","unstructured":"Modi M, Ishimori ML, Sandhu VK, Wallace DJ, Weisman MH. Chest pain in lupus patients: the emergency department experience. Clin Rheumatol. 2015, 34:1969-73. 10.1007\/s10067-015-2948-4","journal-title":"Clin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101589","article-title":"Imaging in large-vessel vasculitis","volume":"34","author":"Schmidt WA","year":"2020","unstructured":"Schmidt WA, Nielsen BD. Imaging in large-vessel vasculitis. Best Pract Res Clin Rheumatol. 2020, 34:101589. 10.1016\/j.berh.2020.101589","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco C","year":"2024","unstructured":"Dejaco C, Ramiro S, Bond M, et al.. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024, 83:741-51. 10.1136\/ard-2023-224543","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich B","year":"2020","unstructured":"Hellmich B, Agueda A, Monti S, et al.. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020, 79:19-30. 10.1136\/annrheumdis-2019-215672","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1117699","article-title":"Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sj\u00f6gren's syndrome: evidence- and practice-based guidance","volume":"14","author":"Marinho A","year":"2023","unstructured":"Marinho A, Delgado Alves J, Fortuna J, et al.. Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sj\u00f6gren's syndrome: evidence- and practice-based guidance. Front Immunol. 2023, 14:1117699. 10.3389\/fimmu.2023.1117699","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221088558","article-title":"Tocilizumab therapy for persistent high-grade fever in systemic lupus erythematosus: two cases and a literature review","volume":"50","author":"Chaoyi M","year":"2022","unstructured":"Chaoyi M, Shrestha B, Hui L, Qiujin D, Ping F. Tocilizumab therapy for persistent high-grade fever in systemic lupus erythematosus: two cases and a literature review. J Int Med Res. 2022, 50:3000605221088558. 10.1177\/03000605221088558","journal-title":"J Int Med Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/life13071496","article-title":"Current treatment approach, emerging therapies and new horizons in systemic lupus erythematosus","volume":"13","author":"Athanassiou P","year":"2023","unstructured":"Athanassiou P, Athanassiou L. Current treatment approach, emerging therapies and new horizons in systemic lupus erythematosus. Life (Basel). 2023, 13:10.3390\/life13071496","journal-title":"Life (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb07112.x","article-title":"Giant cell arteritis and systemic lupus erythematosus","volume":"119","author":"Bunker CB","year":"1988","unstructured":"Bunker CB, Dowd PM. Giant cell arteritis and systemic lupus erythematosus. Br J Dermatol. 1988, 119:115-20. 10.1111\/j.1365-2133.1988.tb07112.x","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/309302-a-rare-case-of-extracranial-giant-cell-arteritis-in-a-patient-with-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:10:50Z","timestamp":1729095050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/309302-a-rare-case-of-extracranial-giant-cell-arteritis-in-a-patient-with-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.71634","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}